Menu
biotium logo
Antibody Finder
Menu

ExoBrite™ CD9 Western Antibody

Validated antibody for optimal detection of EV marker CD9 in extracellular vesicle (EV) extracts by fluorescent western blot or chemiluminescence.

Conjugation
Size
Catalog #
price
Qty
25 tests
100 tests
50 tests
Clear selection

Add to Cart
This product is available by special order only.

Please fill in the inquiry form and we will contact you shortly.

Product Description

ExoBrite™ CD9 Western Antibody is validated by Biotium for optimal detection of extracellular vesicle (EV) marker CD9 in EV extracts by fluorescent western blot. It is available conjugated to ExoBrite™ 680/700 or ExoBrite™ 770/800 near-infrared fluorescent dyes, which offer greater signal-to-noise than visible light fluorescent dyes for western blotting, as well as in an HRP-conjugated format for chemiluminescent detection.

  • Optimal detection of EV marker CD9 by fluorescent western blot or chemiluminescence
  • Validated for use with EV extracts
  • Bright signal and low background
  • Available in 2 near-infrared colors and HRP

EVs, including exosomes, are lipid-bound vesicles that are released from cells. EVs display specific surface proteins and can carry nucleic acids and other cargo, allowing them to transfer biological information between cells in different parts of the body. Therefore EVs are increasingly studied for their potential use in drug delivery and medical diagnostic applications. The most common proteins used as EV markers are CD9, CD63, and CD81, members of the tetraspanin family. Tetraspanins are plasma membrane proteins with many proposed functions, including activation and sorting of other membrane proteins. They are also thought to play a role in the targeting of proteins to multivesicular bodies (MVBs) and exosomes. These tetraspanins are broadly expressed on many cell types and can therefore be detected on many types of EVs, but their expression levels vary depending on the cell type of origin.

EV antibodies you can trust

Other commercially available antibodies for tetraspanin proteins CD9, CD63, and CD81 are generally not validated for isolated EVs and may require tedious optimization for your EV prep and staining protocol. ExoBrite™ Western Antibody Conjugates were validated to offer bright signal and low background of EV markers in EV extracts. ExoBrite™ Calnexin Western Antibody detects a protein of the endoplasmic reticulum that is not found in EVs. It is offered as a negative control to assess the purity of isolated EV extracts.

If you are using secondary antibodies for western detection, Biotium also offers unconjugated recombinant antibodies against CD9, CD63, and CD81. ExoBrite™ Flow Antibody Conjugates are also available for optimal detection of CD9, CD63, and CD81 EV markers by flow cytometry.

For general EV staining, Biotium offers ExoBrite™ stains conjugated to cholera toxin B (CTB), wheat germ agglutinin (WGA), and Annexin V. These stains are specially formulated for bright and specific detection of isolated EVs by flow cytometry. These ExoBrite™ stains may also be combined with antibody staining, for multi-parameter analysis.

Biotium also provides ExoBrite™ STORM Antibodies against CD9, CD63, and CD81, as well as ExoBrite™ STORM CTB EV Stains that use CF® Dyes engineered specifically for high-performance super-resolution imaging by STORM.

ExoBrite™ Western Antibody Conjugates

AntibodyEx/EmConc.SizeCatalog No.
ExoBrite™ 680/700
CD9 Western Antibody
681/698 nm100 ug/mL25 testsP003-680-250
100 testsP003-680-1000
ExoBrite™ 770/800
CD9 Western Antibody
770/797 nm100 ug/mL25 testsP003-770-250
100 testsP003-770-1000
ExoBrite™ HRP
CD9 Western Antibody
N/A100 ug/mL50 testsP003-HRP-500UL
ExoBrite™ 680/700
CD63 Western Antibody
681/698 nm100 ug/mL25 testsP004-680-250
100 testsP004-680-1000
ExoBrite™ 770/800
CD63 Western Antibody
770/797 nm100 ug/mL25 testsP004-770-250
100 testsP004-770-1000
ExoBrite™ HRP
CD63 Western Antibody
N/A100 ug/mL50 testsP004-HRP-500UL
ExoBrite™ 680/700
CD81 Western Antibody
681/698 nm100 ug/mL25 testsP006-680-250
100 testsP006-680-1000
ExoBrite™ 770/800
CD81 Western Antibody
770/797 nm100 ug/mL25 testsP006-770-250
100 testsP006-770-1000
ExoBrite™ HRP
CD81 Western Antibody
N/A100 ug/mL50 testsP006-HRP-500UL
ExoBrite™ 770/800
Calnexin Western Antibody
770/797 nm100 ug/mL25 testsP007-770-250
100 testsP007-770-1000

ExoBrite™ Antibody Target Info

TargetRelevance in EVsReferences for Target in EVsAntibody
CD9Tetraspanin; common EV markerKowal et al., 2016; Théry et al., 2018; Spitzberg et al., 2023ExoBrite™ CD9 Flow Antibody
ExoBrite™ CD9 (Mouse) Flow Antibody
ExoBrite™ CD9 Western Antibody
CD29 (Integrin beta 1)Integrin cell surface glycoprotein found on EV surfaces. Has broad tissue expression and commonly found in EV proteomic analysis.Hoshino et al., 2015; Hazawa et al., 2014; Kugeratski et al., 2021; Spitzberg et al., 2023ExoBrite™ CD29 Flow Antibody
CD47Associates with integrins; regulates trafficking of RNAs into EVs; may contribute to immune evasion on target cells. Has broad tissue expression and commonly found in EV proteomic analysis.Kamerkar et al., 2017; Li et al., 2022; Kugeratski et al., 2021; Spitzberg et al., 2023ExoBrite™ CD47 Flow Antibody
CD63
Tetraspanin; common EV markerEscola et al., 1998; Kowal et al., 2016; Spitzberg et al., 2023ExoBrite™ CD63 Flow Antibody
ExoBrite™ CD63 (Mouse) Flow Antibody
ExoBrite™ CD63 Western Antibody
CD81Tetraspanin; common EV markerEscola et al., 1998; Kowal et al., 2016; Spitzberg et al., 2023ExoBrite™ CD81 Flow Antibody
ExoBrite™ CD81 (Mouse/Rat) Flow Antibody
ExoBrite™ CD81 Western Antibody
CD98 (SLC3A2)Has broad tissue expression and commonly found in EV proteomic analysis.Mathieu et al., 2021; Liao et al., 2024; Tissot et al., 2024; Kugeratski et al., 2021; Spitzberg et al., 2023ExoBrite™ CD98 Flow Antibody

Product Attributes

Antibody number
#P003
SwissProt
P21926
Antibody type
ExoBriteâ„¢, Primary
Clonality
Monoclonal
Host species
Mouse
Isotype
IgG1, kappa
Antibody reactivity (target)
CD9
Synonyms
Tetraspanin-29 (TSPAN29); BA-2/p24 antigen; BA2; BTCC1; CD9; Cell growth-inhibiting gene 2 protein; DRAP27; GIG2; Leukocyte antigen MIC3; MIC3; Motility-related protein (MRP1); p24
Species reactivity
Baboon, Bovine, Cynomolgus monkey, Dog, Horse, Human, Non-human primates, Rabbit, Sheep
Human gene symbol
CD9
Entrez gene ID
928
Unigene
114286
Molecular weight
24 kDa
Antibody target cellular localization
Exosomes/EVs, Plasma membrane
Cell/tissue expression
Exosomes, Platelets, Basophils, Eosinophils, Epithelial cells, Lymphocytes
Verified antibody applications
WB (verified)
Shipping condition
Room temperature
Positive control
MCF-7 cells, MCF-7 derived exosomes
Antibody application notes
Optimal concentration to be determined by end-user, Recommended amount for western blot: 100 ng/mL = 1:1000 dilution
Antibody research areas
Exosomes/EVs
Antibody/conjugate formulation
Fluorescent conjugates: proprietary buffer containing 0.05% sodium azide, HRP conjugates: PBS/50% glycerol/2 mg/mL rBSA
Shelf life
Guaranteed for at least 24 months from date of receipt when stored as recommended
Storage Conditions
Store at 2 to 8 °C, Protect fluorescent conjugates from light
Regulatory status
For research use only (RUO)
Product origin
Product may contain either bovine serum albumin (BSA) from bovine serum (Bos taurus), or recombinant BSA produced in Chinese hamster ovary cells. Inquire for the specific lot.

Documents, Protocols, SDS and COA

FAQs

Exosome & EV Staining

Extracellular vesicles (EVs) are nanoscale, membrane-bound particles released by cells that play important roles in intercellular communication by transporting proteins, lipids, and nucleic acids. Bovine milk is an abundant and accessible source of extracellular vesicles with potential applications in therapeutic delivery, diagnostics, and biomedical research. However, efficiently isolating these vesicles from milk remains challenging due to the complexity of the biological matrix and limitations of conventional isolation methods. Conventional ultracentrifugation or size exclusion chromatography approaches can require expensive, specialized equipment and may produce lower yields or affect vesicle integrity. Developing simpler, scalable, and cost-effective isolation methods could make EV research more accessible to laboratories with limited resources.

In a 2026 BioTechniques publication, Whitney, L. et al. investigated a modified aqueous two-phase system (ATPS) for isolating and characterizing EVs from raw bovine milk. Biotium’s ExoBrite™ 645/675 True EV Membrane Stain was used to fluorescently label the isolated EV membranes for flow cytometry analysis. The researchers combined the membrane stain with antibodies against EV-associated proteins CD63 and TSG101 to confirm the presence and identity of the isolated vesicles. Flow cytometry detected substantial populations of CD63- and TSG101-positive EVs above background, supporting successful EV recovery using the ATPS approach. Additional characterization found that the isolated particles exhibited typical EV morphology and size, as well as protein, lipid, and nucleic acid profiles consistent with extracellular vesicles.

Together, these findings demonstrated that the modified ATPS method can recover intact, biologically relevant EVs from raw bovine milk while requiring less specialized equipment than conventional isolation approaches. These findings are promising toward expanding access to extracellular vesicle research and unlocking the therapeutic and biomedical potential of milk-derived EVs.

By providing reliable fluorescent tools for identifying and characterizing EV populations, Biotium’s ExoBrite™ True EV Membrane Stains can help researchers visualize and distinguish extracellular vesicles during flow cytometry and other analytical workflows, supporting research into EV biology, isolation methods, and potential applications in drug delivery and diagnostics.

Learn more about Biotium’s wide range of EV stains, including ExoBrite™ WGA, CTB, and Annexin V conjugates for bright and sensitive EV surface staining. Biotium also offers ExoBrite™ Flow Antibody Conjugates and ExoBrite™ Antibody Cocktails for optimized detection of EV Markers by flow and fNTA.

ExoBrite™ 645/675 True EV Membrane Stain was used to stain SEC EVs isolated from MCF-7 cells (left panel). The samples were run on a CytoFLEX LX flow cytometer in the R660 (APC) channel. The gated population shows that stained EVs are easily distinguished from background, compared to the dye in buffer alone (right panel).

Full Citation

Whitney, L. S., College, E. R., Peña-Ekker, J., Cannon, C. A., Mason, K. M., Wilson, J. N., & Pullan, J. E., PhD. (2026). Isolation and characterization of bovine-milk derived extracellular vesicles using a modified aqueous two-phase system. BioTechniques, 78(1–12), 55–64. https://doi.org/10.1080/07366205.2026.2633107

Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) are emerging as powerful, cell-free immunomodulatory therapies for inflammatory diseases such as COVID-19. However, because the mechanism is poorly understood, optimizing EV-based therapies remains challenging.

In a 2025 Springer Nature study, Infante et al. investigated how COVID-19 patient serum reshapes the transcriptome and paracrine activity of Wharton’s jelly–derived MSC stem cells (WJ-MSCs). WJ-MCSs exposed to serum from hospitalized COVID patients showed downregulation of NEAT1 and MALAT1, two pro-inflammatory two long noncoding RNAs (lncRNAs). Furthermore, the researchers found that EVs derived from the treated cells had enhanced immunosuppressive activity when administered to T-cells.

The researchers isolated EVs from WJ-MSC cells after NEAT1 and/or MALAT1 knockdown, and tested whether there was an effect on T-cell proliferation. A Western blot of EVs derived from control and lncRNA-knockdown MSCs were probed with ExoBrite™ 680/700 CD81 Western Antibody. ExoBrite™ 770/800 Calnexin Western Antibody was also used as an endoplasmic reticulum marker to assess cellular contamination.

EV enriched samples in control, NEAT1 knockdown, MALAT1 knockdown, and NEAT1/MALAT1-double knockdown were confirmed by bright CD81 detection and the absence of Calnexin. They found that the MALAT1 knockdown EVs were found to have an inhibitory effect on T-cell proliferation. These results illustrate the importance of EV characterization using tools like Biotium’s ExoBrite™ antibodies in translational EV research.

Isolation and characterization of EVs from various lncRNA knock-down WJ-MSCs. Western blot analysis using ExoBrite™ 680/700 CD81 and ExoBrite™ 770/800 Calnexin in EV and MSC lysates. Asterisk (*) indicates reduced conditions used in the MSCs lysate. Modified from Infante et. al. Reproduced under CC BY 4.0.

Learn more about Biotium’s many stains and antibodies for EV research, including ExoBrite™ CD9/CD63/CD81 Antibody Cocktails for flexible and bright multiplexing detection by flow cytometry. Biotium also offers ExoBrite™ stains for pan-EV labeling, optimized fluorescent conjugates of CTB, WGA, and Annexin V for EV detection, ExoBrite™ antibodies for STORM imaging, and more.

Full Citation:

Infante, A., Cabodevilla, L., Gener, B. et al. Modulation of NEAT1 and MALAT1 expression in WJ-MSCs by Covid-19 serum: a foundation for EVs-mediated therapy. Respir Res 26, 313 (2025). https://doi.org/10.1186/s12931-025-03394-4

While early studies of EVs attempted to use first-generation membrane dyes like DiI or PKH to stain EVs, more recently this class of dyes has been found to be largely unsuitable for EV staining due to their high degree of aggregation. Dye aggregation not only generates nonspecific particles that are indistinguishable from EVs in flow cytometry, but also results in poor EV labeling efficiency. Biotium developed the ExoBrite™  True EV Membrane Stains in response to our customers’ difficulties with using traditional membrane dyes to stain EVs. See our Literature Digest for more information.

Can’t find your answer?

Contact Us